SEC Form 4 · accession 0000891293-15-000031

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Global Medical Affairs · Director

Period of report

Aug 28, 2015

Accepted (ET)

Aug 28, 2015 · 6:41 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 28, 2015	S	300	$1.55	D	1,275,619	D
Common Stock	Aug 28, 2015	S	750	$1.56	D	1,274,869	D
Common Stock	Aug 28, 2015	S	50	$1.565	D	1,274,819	D
Common Stock	Aug 28, 2015	S	1,700	$1.57	D	1,273,119	D
Common Stock	Aug 28, 2015	S	6,200	$1.58	D	1,266,919	D
Common Stock	Aug 28, 2015	S	1,200	$1.585	D	1,265,719	D
Common Stock	Aug 28, 2015	S	4,200	$1.59	D	1,261,519	D
Common Stock	Aug 28, 2015	S	200	$1.595	D	1,261,319	D
Common Stock	Aug 28, 2015	S	300	$1.60	D	1,261,019	D
Common Stock	Aug 28, 2015	S	100	$1.605	D	1,260,919	D

No Table II lines on this filing.